# Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment

> **NCT01593891** · — · UNKNOWN · sponsor: **Synergy Health Concepts, Inc.** · enrollment: 45 (actual)

## Conditions studied

- To Determine the Safety and Validity of Venous Angioplasty and
- Valvuloplasty in the Treatment of CCSVI. In Addition, it Will
- Allow Researchers to Sub-classify Valve Morphology in Relation
- to Treatment Success. This Will be Evidenced by Venous Patency
- Forty-eight Hours by Doppler Ultrasound as Well as Clinical
- Symptom Improvement.

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01593891
- **Lead sponsor:** Synergy Health Concepts, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** —
- **Final completion:** 2012-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01593891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01593891, "Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01593891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*